REQUEST A DEMO
Total
USD $0.00
Search more companies

Angiolab Inc. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Angiolab Inc. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved in the manufacturing and sale of pharmaceuticals and functional health food. The pharmaceuticals include obesity treatment, retinopathy treatment, periodontal disease treatments, otitis media treatments, and psoriasis treatments. The functional health food include visceral fat reducing health functional food named Obi-X. In addition, the Company is engaged in the manufacturing and sale of anti-wrinkle cosmetics and deep-sea beard toothpastes. The Company distributes its products within the domestic market and to overseas markets, including America, Europe and Australia. The Company was founded on June 03, 1999. and its shares are listed on KOREA NEW EXCHANGE(KONEX) on October 25, 2016.

Headquarters
65 Techno 3Ro, Yuseong-Gu
Daejeon; Daejeon;

Contact Details: Purchase the Angiolab Inc. report to view the information.

Website: http://www.angiolab.co.kr

Basic Information
Total Employees:
Purchase the Angiolab Inc. report to view the information.
Outstanding Shares:
Purchase the Angiolab Inc. report to view the information.
Financial Auditors:
Purchase the Angiolab Inc. report to view the information.
Incorporation Date:
1999
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Subsidiaries
(주)안지오랩
Company Performance
Financial values in the chart are available after Angiolab Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-50.61%
Total operating revenue
-50.06%
Operating profit (EBIT)
-17.89%
EBITDA
-19.63%
Net Profit (Loss) for the Period
-15.39%
Total assets
-21.58%
Total equity
-53.8%
Operating Profit Margin (ROS)
-283.97%
Net Profit Margin
-267.27%
Return on Equity (ROE)
-70.69%
Debt to Equity Ratio
3.27%
Quick Ratio
-4.31%
Cash Ratio
-0.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?